SARS COV 2

SARS COV 2

Displaying 10 out of 8 results

  1. A phlebotomist takes blood through a finger prick during a Covid-19 antibody test

    COVID-19 was likely present in US from December 2019: Study

    A new antibody testing study published on Tuesday (Jun 15) has found further evidence that the coronavirus was present in the United States from ...
  2. Ep 2
    Media playtime
    48:55minutes

    The Vaccine Quest: Part Two

    The Duke-NUS team is closer to producing a viable vaccine. But creating a viable vaccine is just the first step; producing enough for everyone is ...
  3. New Content Item
    Media playtime
    48:10minutes

    The Vaccine Quest: Part One

    A Singapore-based team has spent the last year developing a COVID-19 vaccine. How close are they to producing one?
  4. Ep 2
    Media playtime
    47:37minutes

    Ep 2: Church Cluster Mystery

    Contact tracers are confounded by a growing cluster of COVID-19 infections at two churches that have no known links to China. Hunting down the ...
  5. New Content Item
    Media playtime
    46:03minutes

    Ep 1: Patient 1

    Contact tracers leap into action as the first COVID-19 case is confirmed in Singapore. They have 24 hours to track and contain this deadly new ...
  6. FILE PHOTO: A mink is seen at the farm of the representative of the Panhellenic association of fur

    France rules out mutated COVID-19 in mink farm case

    A coronavirus outbreak detected last month on a mink farm in France did not involve a mutated strain of the virus, the agriculture ministry said ...
  7. A 3D-printed coronavirus model is seen on display in this illustration

    T-cell study adds to debate over duration of COVID-19 immunity

    A small UK study has found that "cellular immunity" to the pandemic SARS-CoV-2 virus is present after six months in people who had mild or ...
  8. FILE PHOTO: A MTA staff uses a Lysol to clean a station at the lobby of Grand Central Station follo

    Exclusive: Lonza expects EPA approval coming 'very soon' to make COVID-killing claims for disinfectants on surfaces

    Lonza Group AG is in the “last step” of discussions with U.S. regulators for approval to claim that its formulation is effective in killing the ...